Incidence and treatment of methicillin-resistant S. aureus infection in cystic fibrosis patients: a cohort study

详细信息    查看全文

• 作者：Paloma Horejs Bittencourt^a ; Carlos Sidney Silva Pimentel^a ; Bianca Sampaio Bonfim^a ; Paulo José ; Marostica^b ; Edna Lú ; cia Souza^a ; ^c ; ^{souza.ednalucia@gmail.com}
• 关键词：Antibiotic therapy ; Methicillin-resistant Staphylococcus aureus ; Brazil ; Pediatrics ; therapy
• 刊名：The Brazilian Journal of Infectious Diseases
• 出版年：2017
• 出版时间：January-February 2017
• 年：2017
• 卷：21
• 期：1
• 页码：107-111
• 全文大小：456 K
• 卷排序：21

文摘

In Brazil the knowledge about methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients is scarce. This study aimed to determine the incidence of respiratory tract colonization and the identification rates after a standardized treatment. A retrospective cohort was performed highlighting the history of respiratory colonizations between January 2008 and June 2015. Patients under the age of 21 years with cystic fibrosis confirmed by sweat test or genetic study receiving care at the outpatient clinics of a Teaching Hospital were included. The treatment consisted of trimethoprim/sulfamethoxazole, rifampicin, nasal mupirocin and chlorhexidine 2%. The mean follow-up period was of 22.2 months and those with ≥3 negative cultures were considered free of methicillin-resistant Staphylococcus aureus. Forty-two patients were included. Methicillin-resistant Staphylococcus aureus was identified in six patients. Most patients had methicillin-sensitive S. aureus isolation prior to methicillin-resistant Staphylococcus aureus. Five children used the standardized treatment, none presented side effects. Only one child had a new isolation of methicillin-resistant Staphylococcus aureus during follow-up (after 20 months). The incidence of methicillin-resistant Staphylococcus aureus infection was high and occurred in young patients. The therapeutic regimen was effective, safe and being a good option to treat methicillin-resistant Staphylococcus aureus infection.